Fomepizole
Fomepizole (fomepizole) is a small molecule pharmaceutical. Fomepizole was first approved as Antizol on 1997-12-04. It is used to treat poisoning in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| chemically-induced disorders | D064419 |
Trade Name
FDA
EMA
Fomepizole (discontinued: Antizol, Fomepizole)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Fomepizole
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ANTIZOL | Par Pharmaceutical | N-020696 DISCN | 1997-12-04 | 1 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| antizol | New Drug Application | 2009-07-27 |
| fomepizole | ANDA | 2023-10-26 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| poisoning | EFO_0008546 | D011041 | T65.91 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Fomepizole, Antizol, Par Pharm Inc | |||
| 7553863 | 2027-06-30 | DS, DP | |
HCPCS
Code | Description |
|---|---|
| J1451 | Injection, fomepizole, 15 mg |
Clinical
Clinical Trials
119 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 2 | 3 | 3 | 1 | — | 7 |
| Plasma cell neoplasms | D054219 | — | — | 2 | 3 | 3 | 1 | — | 7 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | 2 | — | 2 |
| Colitis | D003092 | EFO_0003872 | K52.9 | — | 1 | — | 1 | — | 2 |
| Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | — | 1 | — | 1 | — | 2 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 1 | — | 1 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | 1 | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | 1 | — | 1 |
| Ulcer | D014456 | MPATH_579 | — | — | — | — | 1 | — | 1 |
| Fibrosis | D005355 | — | — | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 3 | 21 | 28 | — | 1 | 50 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 3 | 22 | 23 | — | 2 | 47 |
| Lymphoid leukemia | D007945 | — | C91 | 3 | 21 | 21 | — | 2 | 44 |
| Lymphoma | D008223 | — | C85.9 | 1 | 6 | 6 | — | — | 11 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 5 | 4 | — | — | 9 |
| Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 1 | 3 | 4 | — | — | 7 |
| Philadelphia chromosome | D010677 | — | — | — | 3 | 3 | — | — | 6 |
| Promyelocytic leukemia acute | D015473 | — | C92.4 | — | — | 4 | — | — | 4 |
| Down syndrome | D004314 | EFO_0001064 | Q90 | — | 2 | 2 | — | — | 4 |
| Syndrome | D013577 | — | — | — | 2 | 1 | — | 1 | 4 |
Show 15 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | 1 | 4 |
| Recurrence | D012008 | — | — | 1 | 3 | — | — | — | 3 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | — | — | 2 | 3 |
| Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | 2 | 3 |
| Anemia | D000740 | HP_0001903 | D64.9 | 1 | 2 | — | — | — | 2 |
| Fanconi anemia | D005199 | Orphanet_84 | D61.09 | 1 | 2 | — | — | — | 2 |
| Eye diseases | D005128 | EFO_0003966 | H44 | — | 1 | — | — | 1 | 2 |
| Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
| Precursor b-cell lymphoblastic leukemia-lymphoma | D015452 | — | — | — | 1 | — | — | — | 1 |
| Hermanski-pudlak syndrome | D022861 | — | E70.331 | — | 1 | — | — | — | 1 |
Show 22 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Macular degeneration | D008268 | EFO_0001365 | H35.30 | 1 | — | — | — | 1 | 2 |
| Stargardt disease | D000080362 | — | H35.53 | 1 | — | — | — | — | 1 |
| Hereditary corneal dystrophies | D003317 | HP_0007802 | H18.5 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 3 | 3 |
| Glaucoma | D005901 | EFO_0000516 | H40 | — | — | — | — | 3 | 3 |
| Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 1 | 1 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 1 | 1 |
| Communicable diseases | D003141 | — | — | — | — | — | — | 1 | 1 |
| Mycoplasma infections | D009175 | — | — | — | — | — | — | 1 | 1 |
| Pleuropneumonia | D011001 | — | — | — | — | — | — | 1 | 1 |
| Choroidal neovascularization | D020256 | — | — | — | — | — | — | 1 | 1 |
| Pathologic neovascularization | D009389 | — | — | — | — | — | — | 1 | 1 |
| Anesthesia | D000758 | — | — | — | — | — | — | 1 | 1 |
Show 35 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Fomepizole |
| INN | fomepizole |
| Description | Fomepizole is a member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4. It has a role as an antidote, a protective agent and an EC 1.1.1.1 (alcohol dehydrogenase) inhibitor. It derives from a hydride of a 1H-pyrazole. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1cn[nH]c1 |
Identifiers
| PDB | — |
| CAS-ID | 7554-65-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1308 |
| ChEBI ID | 5141 |
| PubChem CID | 3406 |
| DrugBank | DB01213 |
| UNII ID | 83LCM6L2BY (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,073 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
124 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use